168 results
8-K
EX-10.1
STAB
Statera Biopharma, Inc.
15 Nov 22
Entry into a Material Definitive Agreement
6:04am
8-K
EX-10.1
STAB
Statera Biopharma, Inc.
4 Nov 22
Entry into a Material Definitive Agreement
9:51pm
10-Q
2022 Q2
EX-10.3
STAB
Statera Biopharma, Inc.
Quarterly report
28 Oct 22
8:49am
8-K
EX-10.1
STAB
Statera Biopharma, Inc.
24 Oct 22
Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF
6:08am
10-Q
2022 Q1
EX-10.3
STAB
Statera Biopharma, Inc.
Quarterly report
21 Oct 22
9:00am
8-K
EX-10.1
yuo7lo3ro bth
17 Oct 22
Entry into a Material Definitive Agreement
5:30pm
8-K
EX-10.1
122e2
8 Sep 22
Entry into a Material Definitive Agreement
6:55pm
8-K
EX-10.1
g2gqg 2hp8l
22 Jun 22
Departure of Directors or Certain Officers
3:58pm
8-K
EX-10.1
17q95wab2uam5
22 Mar 22
Entry into a Material Definitive Agreement
9:20am
8-K
EX-10.1
vh2fz00t4yz 4hup
7 Feb 22
Statera Biopharma Announces Pricing of $2.0 Million Registered Direct Offering
2:59pm
8-K
EX-10.2
9oy8 7huxwi
7 Feb 22
Statera Biopharma Announces Pricing of $2.0 Million Registered Direct Offering
2:59pm
8-K
EX-10.3
ukrf9ajc
2 Aug 21
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.7
5tcv64fm
2 Aug 21
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.5
ajj8tw7fbjkd mq
2 Aug 21
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.4
lzx eta60
2 Aug 21
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.2
o33620 r2
2 Aug 21
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.6
h6z65kp0iy
2 Aug 21
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.1
qeqiyi 65sm2mu
2 Aug 21
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.3
fuz85zdpmo5yjm
28 Jul 21
Cytocom Inc. Announces Completed Merger with Cleveland BioLabs
8:30am
8-K
EX-10.5
niha 4pyt
28 Jul 21
Cytocom Inc. Announces Completed Merger with Cleveland BioLabs
8:30am